NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

54 hedge funds and large institutions have $2.8M invested in Navidea Biopharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
–
Holders Change %
0%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Invesco
1
Invesco
Georgia
$11K
2
VF
2
Virtu Financial
New York
$9K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$5K
4
SIS
4
Sound Income Strategies
Florida
$3K
5
UBS Group
5
UBS Group
Switzerland
$13K

Top Sellers

1
BCM
1
Bridgeway Capital Management
Texas
$20K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$81K
3
Wells Fargo
3
Wells Fargo
California
$22K
4
GC
4
Guggenheim Capital
Illinois
$0
5
GWM
5
Greenwich Wealth Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
51
Jane Street
New York
– -$11K -1,508 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– -$5K -744 Closed
MML Investors Services
53
MML Investors Services
Massachusetts
– -$5K -700 Closed
1 2
3